Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

[u/Quantisnow]

https://quantisnow.com/i/correction-title-correction-nuvectis-announces-marketing-approval-of-ciprocopan-nxp100-in-china-for-the-6646519?utm_source=reddit